Related Experiment Video
Updated: Sep 18, 2025
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
628
Thyroid Eye Disease: Management, Advances, and Future Opportunities.
Tamaryn Fox1, Andrea Kossler2, Chrysoula Dosiou1
1Division of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Summary
Thyroid eye disease (TED) treatments are advancing, with new drugs like teprotumumab and emerging therapies showing promise. Research also focuses on novel surgical techniques and AI to improve diagnosis and patient outcomes for this vision-threatening autoimmune condition.
Area of Science:
- Ophthalmology and Endocrinology
- Autoimmune disease research
- Medical technology innovation
Background:
- Thyroid eye disease (TED), an extrathyroidal manifestation of Graves disease, is a severe autoimmune disorder.
- TED significantly impairs quality of life and poses a risk to vision.
- Current understanding of TED pathophysiology is evolving.
Purpose of the Study:
- To review recent advancements in Thyroid eye disease (TED) research.
- To highlight emerging treatments, surgical techniques, and diagnostic tools.
- To explore the role of artificial intelligence (AI) in managing TED.
Main Methods:
- Comprehensive literature review of recent studies on TED.
- Analysis of clinical trial data for novel therapeutic agents.
- Evaluation of new surgical and diagnostic technologies, including AI applications.
Main Results:
- Teprotumumab, an FDA-approved drug, demonstrates efficacy in reducing proptosis and diplopia.
- Several novel therapies targeting different pathways are in development, showing potential.
- Minimally invasive surgical techniques and AI tools are emerging for diagnosis and treatment prediction.
Conclusions:
- Significant progress has been made in understanding and treating TED.
- Emerging therapies and advanced technologies offer new hope for patients.
- Continued research is crucial for refining diagnostic precision and therapeutic strategies in TED management.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
5.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.2K
01:23The Thyroid Gland
4.4K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.4K
01:27Open Angle Glaucoma: Treatment
591
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
591
01:25Glaucoma: Overview
789
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
789
01:28Angle Closure Glaucoma: Treatment
708
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
708
01:18Functions of Thyroid Hormones
3.2K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.2K